Search Results

There are 7183 results for: content related to: Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity

  1. You have free access to this content
    Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function

    British Journal of Clinical Pharmacology

    Volume 80, Issue 2, August 2015, Pages: 253–266, Lot A. Devriese, Petronella (Els). O. Witteveen, Marja Mergui-Roelvink, Deborah A. Smith, Lionel D. Lewis, David S. Mendelson, Yung-Jue Bang, Hyun Choel Chung, Mohammed M. Dar, Alwin D. R. Huitema, Jos H. Beijnen, Emile E. Voest and Jan H. M. Schellens

    Version of Record online : 20 MAY 2015, DOI: 10.1111/bcp.12606

  2. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 3, March 2012, Pages: 372–382, Chunlei Li, Caixia Wang, Hanyu Yang, Xi Zhao, Na Wei and Jingxia Cui

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01422.x

  3. Topotecan for ovarian cancer

    Intervention Review

    The Cochrane Library

    Peng Lihua, Xiao Y Chen and Taixiang Wu

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD005589.pub2

  4. Clinical use of topoisomerase I inhibitors in anticancer treatment

    Medical and Pediatric Oncology

    Volume 35, Issue 4, 1 October 2000, Pages: 385–402, Carlos Rodriguez-Galindo, Kristine Radomski, Clinton F. Stewart, Wayne Furman, Victor M. Santana and Peter J. Houghton

    Version of Record online : 3 OCT 2000, DOI: 10.1002/1096-911X(20001001)35:4<385::AID-MPO1>3.0.CO;2-E

  5. A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer

    The Journal of Clinical Pharmacology

    Volume 50, Issue 3, March 2010, Pages: 268–275, Dr Kelly K. Curtis, Ms Jean T. Hartney, Dr Roxanne C. Jewell, Dr Jung W. Park, Dr Peter F. Lebowitz, Ms Pamela P. Griffin, Dr Mitesh J. Borad, Dr Tom R. Fitch and Dr Donald W. Northfelt

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343699

  6. Topotecan in cervical cancer

    International Journal of Gynecological Cancer

    Volume 17, Issue 6, November/December 2007, Pages: 1215–1223, S. ACKERMANN, M. W. BECKMANN, F. THIEL and T. BOGENRIEDER

    Version of Record online : 20 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01003.x

  7. Camptothecin and Its Analogs

    Annals of the New York Academy of Sciences

    Volume 803, Issue 1, December 1996, Pages: 213–223, FRANCO M. MUGGIA, ISAIAH DIMERY and SUSAN G. ARBUCK

    Version of Record online : 17 DEC 2006, DOI: 10.1111/j.1749-6632.1996.tb26391.x

  8. You have free access to this content
    Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

    British Journal of Pharmacology

    Volume 172, Issue 16, August 2015, Pages: 4089–4106, Kenneth K W To, Daniel C Poon, Yuming Wei, Fang Wang, Ge Lin and Liwu Fu

    Version of Record online : 26 JUN 2015, DOI: 10.1111/bph.13189

  9. Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole blood

    Biomedical Chromatography

    Volume 23, Issue 7, July 2009, Pages: 707–713, K. Elaine Hubbard, Paula Schaiquevich, Feng Bai, Charles H. Fraga, Laura Miller, John C. Panetta and Clinton F. Stewart

    Version of Record online : 10 MAR 2009, DOI: 10.1002/bmc.1173

  10. Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

    Pediatric Blood & Cancer

    Volume 62, Issue 4, April 2015, Pages: 598–602, A. M. C. Mavinkurve-Groothuis, M. M. van den Heuvel-Eibrink, G. A. Tytgat, H. van Tinteren, G. Vujanic, K. L. P. Pritchard-Jones, L. Howell, N. Graf, C. Bergeron, T. Acha, S. Catania and F. Spreafico

    Version of Record online : 29 DEC 2014, DOI: 10.1002/pbc.25357

  11. Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma

    International Journal of Gynecological Cancer

    Volume 15, Issue 4, July 2005, Pages: 612–617, B. PIURA and A. RABINOVICH

    Version of Record online : 7 JUL 2005, DOI: 10.1111/j.1525-1438.2005.00116.x

  12. Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography

    Biomedical Chromatography

    Volume 21, Issue 11, November 2007, Pages: 1191–1200, Nienke A. de Vries, Mariët Ouwehand, Tessa Buckle, Jos H. Beijnen and Olaf van Tellingen

    Version of Record online : 21 JUN 2007, DOI: 10.1002/bmc.874

  13. Ocular topotecan pharmacokinetics following topical administration to rabbits for diffused anterior retinoblastoma

    Journal of Pharmacy and Pharmacology

    Paula Taich, Maria Del Sole, Fabian Buontempo, Gustavo Williams, Ursula Winter, Mariana Sgroi, Guillermo Chantada and Paula Schaiquevich

    Version of Record online : 30 AUG 2016, DOI: 10.1111/jphp.12624

  14. A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 17, Issue 2, March/April 2007, Pages: 367–372, F. VECCHIONE, R. FRUSCIO, T. DELL’ANNA, A. GARBI, R. GARCIA PARRA, S. CORSO and A.A. LISSONI

    Version of Record online : 11 JAN 2007, DOI: 10.1111/j.1525-1438.2007.00797.x

  15. You have free access to this content
    Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan

    Journal of Neurochemistry

    Volume 125, Issue 1, April 2013, Pages: 7–15, Yukiko Nakamura, Yusuke Ishida, Takahiro Yamada, Makoto Kondo and Shoichi Shimada

    Version of Record online : 31 JAN 2013, DOI: 10.1111/jnc.12146

  16. A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study

    Pediatric Blood & Cancer

    Volume 60, Issue 4, April 2013, Pages: 627–632, Susan M. Blaney, Michael Tagen, Arzu Onar-Thomas, Stacey L. Berg, Sri Gururangan, Kathleen Scorsone, Jack Su, Stewart Goldman, Mark W. Kieran, Larry Kun, Jim Boyett and Clinton Stewart

    Version of Record online : 21 SEP 2012, DOI: 10.1002/pbc.24309

  17. Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan

    Pediatric Blood & Cancer

    Volume 62, Issue 11, November 2015, Pages: 1886–1891, Kathelijne C.J.M. Kraal, Godelieve A.M. Tytgat, Berthe L.F. van Eck-Smit, Boen Kam, Huib N. Caron and Max van Noesel

    Version of Record online : 15 MAY 2015, DOI: 10.1002/pbc.25580

  18. Clinical Studies of Topotecan

    Annals of the New York Academy of Sciences

    Volume 803, Issue 1, December 1996, Pages: 264–271, COLIN BROOM

    Version of Record online : 17 DEC 2006, DOI: 10.1111/j.1749-6632.1996.tb26396.x

  19. Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

    Journal of Surgical Oncology

    Volume 72, Issue 3, November 1999, Pages: 162–169, Sharad A. Ghamande and M. Steven Piver

    Version of Record online : 15 NOV 1999, DOI: 10.1002/(SICI)1096-9098(199911)72:3<162::AID-JSO9>3.0.CO;2-0

  20. Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors

    Pediatric Blood & Cancer

    Volume 42, Issue 1, January 2004, Pages: 93–98, Daniel C. Bowers, Victor M. Aquino, Patrick J. Leavey, Robert O. Bash, Janna M. Journeycake, Gail Tomlinson, Arlynn F. Mulne, Heidi J. Haynes and Naomi J. Winick

    Version of Record online : 5 NOV 2003, DOI: 10.1002/pbc.10456